Back to Search Start Over

Advaxis Announces Notice of Allowance of US Patent for ADXS-HPV Immunotherapy

Source :
Business Wire. October 18, 2011
Publication Year :
2011

Abstract

PRINCETON, N.J. -- Advaxis, Inc ., (OTCBB: ADXS) , a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced that the United States Patent [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Business Wire
Publication Type :
News
Accession number :
edsgcl.270044191